Repetitive administration of Shaoyao-Gancao-tang to rats restores the bioavailability of glycyrrhizin reduced by antibiotic treatment

Journal of Pharmacy and Pharmacology

Volumn 55, Issue 11, 2003, Pages 1569-1575

  He, Ju Xiu ^a   Akao, Teruaki ^b   Tani, Tadato ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Med and Pharmaceutical University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CHINESE DRUG; DRUG METABOLITE; GLYCOSIDE; GLYCYRRHETINIC ACID; GLYCYRRHIZA EXTRACT; GLYCYRRHIZIC ACID; METRONIDAZOLE; OFLOXACIN; PAEONIA RADIX; SHAOYAO GANCAO TANG; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CHINESE MEDICINE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG HALF LIFE; DRUG METABOLISM; DRUG TRANSFORMATION; FECES; INTESTINE FLORA; MALE; NONHUMAN; PEPTIC ULCER; RAT; SINGLE DRUG DOSE;

EID: 0344444779     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357022124     Document Type: Article

References (26)

1. Abe, M., Atsumi, N., Matsushita, S., Mitsui, T. (2001) Recovery of high-frequency QRS potentials following cardioplegic arrest in pediatric cardiac surgery. Pediatr. Cardiol. 22: 315-320
2. Akao, T., Akao, T., Kobashi, K. (1987) Glycyrrhizin beta-D-glucuronidase of Eubacterium sp. from human intestinal flora. Chem. Pharm. Bull. 35: 705-710
3. Akao, T., Akao, T., Kobashi, K. (1988) Glycyrrhizin stimulates growth of Eubacterium sp. strain GLH, a human intestinal anaerobe. Appl. Environ. Microbiol. 54: 2027-2030
4. Akao, T., Hayashi, T., Kobashi, K., Kanaoka, M., Kato, H., Kobayashi, M., Takeda, S., Oyama, T. (1994) Intestinal bacterial hydrolysis is indispensable to absorption of 18 beta-glycyrrhetic acid after oral administration of glycyrrhizin in rats. J. Pharm. Pharmacol. 46: 135-137
5. Akase, T., Hamada, Y., Higashiyama, D., Akase, T., Tashiro, S., Sagawa, K., Shimada, S. (2002) Trends in the prescriptions of Kampo medicines over a six-year period. J. Trad. Med. 19: 58-75
6. Aldridge, K. E., Sanders, C. V., Lewis, A. C., Marier, R. L. (1983) Susceptibility of anaerobic bacteria to beta-lactam antibiotics and beta-lactamase production. J. Med. Microbiol. 16: 75-82
7. Bando, M., Shibahara, N., Shimada, Y., Meselhy, M. R., Akao, T., Itoh, T., Terasawa, K. (2000) Pharmacokinetic study of paeoniflorin, paeonimetabolin-I and glycyrrhetic acid in humans after oral administration of Paeony root, Glycyrrhiza and Shakuyaku-kanzo-to (Shao-Yao-Gan-Cao-Tang). J. Trad. Med. 17: 26-33
8. Boxenbaum, H. (1982) Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. J. Pharmacokinet. Biopharm. 10: 201-227
9. Drew, R. H., Gallis, H. A. (1988) Ofloxacin: Its pharmacology, pharmacokinetics, and potential for clinical application. Pharmacotherapy 8: 35-46
10. Hasegawa, T., Yamaki, K., Muraoka, I., Nadai, M., Takagi, K., Nabeshima, T. (1995) Effects of traditional Chinese medicines on pharmacokinetics of levofloxacin. Antimicrob. Agents Chemother. 39: 2135-2137
11. He, J.-X., Akao, T., Nishino, T., Tani, T. (2001) The influence of commonly prescribed synthetic drugs for peptic ulcer on the pharmacokinetic fate of glycyrrhizin from Shaoyao-Gancao-tang. Biol. Pharm. Bull. 24: 1395-1399
12. He, J-X., Akao, T., Tani, T. (2003) The influence of co-administered antibiotics on the pharmacokinetic fate in rats of paeoniflorin and its active metabolite paeonimetabolin-I from Shaoyao-Gancao-tang. J. Pharm. Pharmacol. 55: 313-321
13. Holtbecker, N., Fromm, M. F., Kroemer, H. K., Ohnhaus, E. E., Heidemann, H. (1996) The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism. Drug Metab. Dispos. 24: 1121-1123
14. Katsura, T. (1995) The remarkable effect of Kanzo-to and Shakuyakukanzo-to in the treatment of acute abdominal pain. Jpn. J. Orient. Med. 46: 293-299
15. Kobashi, K., Akao, T., Hattori, M., Namba, T. (1992) Metabolism of drugs by intestinal bacteria. Bifidobacteria Microflora 11: 9-23
16. Kuhlmann, J., Muck, W. (2001) Clinical-pharmacological strategies to assess drug interaction potential during drug development. Drug Safety 24: 715-725
17. Lebsack, M. E., Nix, D., Ryerson, B., Toothaker, R. D., Welage, L., Norman, A. M., Schentag, J. J., Sedman, A. J. (1992) Effect of gastric acidity on enoxacin absorption. Clin. Pharmacol. Ther. 52: 252-256
18. Nishimura, N., Naora, K., Hirano, H., Iwamoto, K. (1998) Effects of Sho-saiko-to on the pharmacokinetics and pharmacodynamics of tolbutamide in rats. J. Pharm. Pharmacol. 50: 231-236
19. Oguri, T., Kosakai, N. (1979) Comparison of the antibacterial activity of ticarcillin with other antibacterial agents. Jpn J. Antibiot. 32: 729-743
20. Ohnishi, N., Okada, K., Yoshioka, M., Kuroda, K., Nagasawa, K., Takara, K., Yokoyama, T. (2002) Studies on interactions between traditional herbal and western medicines. V. Effects of Sho-saiko-to (Xiao-Cai-hu-Tang) on the pharmacokinetics of carbamazepine in rats. Biol. Pharm. Bull. 25: 1461-1466
21. Sakamoto, H., Hirose, T., Mine, Y. (1985) Pharmacokinetics of FK027 in rats and dogs. J. Antibiot. 38: 496-504
22. Takagi, K., Okabe, S., Saziki, R. (1969) A new method for the production of chronic gastric ulcer in rats and the effect of several drugs on its healing. Jpn. J. Pharmacol. 19: 418-426
23. Tatro, D. S. (2002) Drug Interaction Facts 2003. 11th edn, Facts & Comparisons, Saint Louis
24. Welling, P. G., Huang, H., Koch, P. A., Craig, W. A., Madsen, P. O. (1977) Bioavailability of ampicillin and amoxicillin in fasted and nonfasted subjects. J. Pharm. Sci. 66: 549-552
25. Wu, B., Ignotz, G., Currie, W. B., Yang, X. (1997) Dynamics of maturation-promoting factor and its constituent proteins during in vitro maturation of bovine oocytes. Biol. Reprod. 56: 253-259
26. Yamaguchi, T., Goto, H., Ishida, G., Miyagawa, I., Fukuda, K., Hirakawa, S. (1982) Clinical experience of Choreito and Shakuyakukanzoto to ureteral stone. Nishinihon J. Urol. 44: 337-341